Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953894077> ?p ?o ?g. }
- W2953894077 endingPage "107678" @default.
- W2953894077 startingPage "107678" @default.
- W2953894077 abstract "There is unmet need to design an analgesic with fewer side effects for severe pain management. Although traditional opioids are the most effective painkillers, they are accompanied by severe adverse responses, such as respiratory depression, constipation symptoms, tolerance, withdrawal, and addiction. We indicated BPR1M97 as a dual mu opioid receptor (MOP)/nociceptin-orphanin FQ peptide (NOP) receptor full agonist and investigated the pharmacology of BPR1M97 in multiple animal models. In vitro studies on BPR1M97 were assessed using cyclic-adenosine monophosphate production, β-arrestin, internalization, and membrane potential assays. In vivo studies were characterized using the tail-flick, tail-clip, lung functional, heart functional, acetone drop, von Frey hair, charcoal meal, glass bead, locomotor activity, conditioned place preference (CPP) and naloxone precipitation tests. BPR1M97 elicited full agonist properties for all cell-based assays tested in MOP-expressing cells. However, it acted as a G protein-biased agonist for NOP. BPR1M97 initiated faster antinociceptive effects at 10 min after subcutaneous injection and elicited better analgesia in cancer-induced pain than morphine. Unlike morphine, BPR1M97 caused less respiratory, cardiovascular, and gastrointestinal dysfunction. In addition, BPR1M97 decreased global activity and induced less withdrawal jumping precipitated by naloxone. Thus, BPR1M97 could serve as a novel small molecule dual receptor agonist for antinociception with fewer side effects than morphine. This article is part of the Special Issue entitled ‘New Vistas in Opioid Pharmacology’." @default.
- W2953894077 created "2019-07-12" @default.
- W2953894077 creator A5004952365 @default.
- W2953894077 creator A5005296056 @default.
- W2953894077 creator A5008243155 @default.
- W2953894077 creator A5010909839 @default.
- W2953894077 creator A5013661718 @default.
- W2953894077 creator A5014354004 @default.
- W2953894077 creator A5020095155 @default.
- W2953894077 creator A5024560459 @default.
- W2953894077 creator A5033562862 @default.
- W2953894077 creator A5061801210 @default.
- W2953894077 creator A5068298084 @default.
- W2953894077 creator A5071717389 @default.
- W2953894077 date "2020-04-01" @default.
- W2953894077 modified "2023-10-14" @default.
- W2953894077 title "BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine" @default.
- W2953894077 cites W1521031730 @default.
- W2953894077 cites W1593555249 @default.
- W2953894077 cites W1635709196 @default.
- W2953894077 cites W1898469558 @default.
- W2953894077 cites W1973640136 @default.
- W2953894077 cites W1977002226 @default.
- W2953894077 cites W1980944689 @default.
- W2953894077 cites W1981952236 @default.
- W2953894077 cites W1988795126 @default.
- W2953894077 cites W1996632262 @default.
- W2953894077 cites W1996719014 @default.
- W2953894077 cites W2011863697 @default.
- W2953894077 cites W2014237020 @default.
- W2953894077 cites W2015087988 @default.
- W2953894077 cites W2021507718 @default.
- W2953894077 cites W2022297768 @default.
- W2953894077 cites W2025043134 @default.
- W2953894077 cites W2030085641 @default.
- W2953894077 cites W2035406273 @default.
- W2953894077 cites W2040668587 @default.
- W2953894077 cites W2041826062 @default.
- W2953894077 cites W2044746762 @default.
- W2953894077 cites W2055457973 @default.
- W2953894077 cites W2056353612 @default.
- W2953894077 cites W2061923218 @default.
- W2953894077 cites W2065713281 @default.
- W2953894077 cites W2085223462 @default.
- W2953894077 cites W2085879736 @default.
- W2953894077 cites W2098671499 @default.
- W2953894077 cites W2100769753 @default.
- W2953894077 cites W2103615321 @default.
- W2953894077 cites W2104096262 @default.
- W2953894077 cites W2109083102 @default.
- W2953894077 cites W2126059273 @default.
- W2953894077 cites W2126551113 @default.
- W2953894077 cites W2127461273 @default.
- W2953894077 cites W2140288698 @default.
- W2953894077 cites W2147243399 @default.
- W2953894077 cites W2150803160 @default.
- W2953894077 cites W2153333501 @default.
- W2953894077 cites W2158094690 @default.
- W2953894077 cites W2158906680 @default.
- W2953894077 cites W2165004472 @default.
- W2953894077 cites W2165671231 @default.
- W2953894077 cites W2172201406 @default.
- W2953894077 cites W2257306395 @default.
- W2953894077 cites W2405780933 @default.
- W2953894077 cites W2412243856 @default.
- W2953894077 cites W2418558247 @default.
- W2953894077 cites W2499653477 @default.
- W2953894077 cites W2507900361 @default.
- W2953894077 cites W2512819857 @default.
- W2953894077 cites W2522786792 @default.
- W2953894077 cites W2581223948 @default.
- W2953894077 cites W2588925684 @default.
- W2953894077 cites W2596333230 @default.
- W2953894077 cites W2596568068 @default.
- W2953894077 cites W2757786577 @default.
- W2953894077 cites W2792983781 @default.
- W2953894077 cites W2888586383 @default.
- W2953894077 cites W2889071092 @default.
- W2953894077 cites W2063573100 @default.
- W2953894077 doi "https://doi.org/10.1016/j.neuropharm.2019.107678" @default.
- W2953894077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31278929" @default.
- W2953894077 hasPublicationYear "2020" @default.
- W2953894077 type Work @default.
- W2953894077 sameAs 2953894077 @default.
- W2953894077 citedByCount "11" @default.
- W2953894077 countsByYear W29538940772020 @default.
- W2953894077 countsByYear W29538940772021 @default.
- W2953894077 countsByYear W29538940772022 @default.
- W2953894077 countsByYear W29538940772023 @default.
- W2953894077 crossrefType "journal-article" @default.
- W2953894077 hasAuthorship W2953894077A5004952365 @default.
- W2953894077 hasAuthorship W2953894077A5005296056 @default.
- W2953894077 hasAuthorship W2953894077A5008243155 @default.
- W2953894077 hasAuthorship W2953894077A5010909839 @default.
- W2953894077 hasAuthorship W2953894077A5013661718 @default.
- W2953894077 hasAuthorship W2953894077A5014354004 @default.
- W2953894077 hasAuthorship W2953894077A5020095155 @default.
- W2953894077 hasAuthorship W2953894077A5024560459 @default.